Merck & CompanyvsShoulder Innovations

MRK and SI stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$144.46

Value $357B

+0.55%
MRK's page

SI

Shoulder Innovations, Inc.

$20.45

Value $422M

-1.85%
SI's page

Merck & Company (MRK) has a market value of $357B and Shoulder Innovations (SI) $422M. Over the last year, with dividends, MRK moved +66.3% and SI +37.9%. Dividend yield: MRK 2.35%, SI none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$357B

    SI$422M

    MRK is 846 times SI

  • Revenue, 12 months

    MRK$67.4B

    SI$64M

    MRK is 1,045 times SI

  • Net income, 12 months

    MRK$2.5B

    SI-$33M

  • Operating margin

    MRK–

    SI-54.4%

  • ROIC

    MRK3.9%

    SI-18.8%

    22.7 points apart

  • P/E

    MRK145.6

    SI–

  • Dividend yield

    MRK2.4%

    SI0.0%

    2.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+66.3%

SI+37.9%

100125150175DecFebAprJunAugOct
Returns by period
PeriodMRKWith dividendsSIWith dividends
1 year since November 12, 2025+66.3%Price +61.6%+37.9%Price +37.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanySIShoulder Innovations

Valuation

MRKSI
Valuation
Price$144.46$20.45
Market value$357B$422M
Enterprise value (EV)$401B$345M
P/E145.6–
P/E, 5-year median14.8–
P/B8.03.6
EV/EBIT84.3–
Free cash flow yield4.1%–

Results and growth

MRKSI
Results and growth
Revenue, 12 months$67.4B$64M
Net income, 12 months$2.5B-$33M
Free cash flow, 12 months$14.7B-$43M
Earnings per share, 12 months$0.98$1.11
Revenue growth, year on year1.3%49.6%
Revenue growth a year, past+9.4%over 5 years+49.6%over 1 years
EPS growth a year, past+21.2%over 5 years–

Margins and returns on capital

MRKSI
Margins and returns on capital
Gross margin71.8%77.8%
Operating margin–-54.4%
Net margin3.6%-51.7%
ROIC3.9%-18.8%
ROE5.2%-25.1%

Balance sheet

MRKSI
Balance sheet
Cash$9.7B$92M
Total debt$53.8B$15M
Net debt / EBITDA5.7–
Interest cover2.4×–

Dividends and buybacks

MRKSI
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$3.40–
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.4%–
Shareholder yield3.8%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or SI

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or Shoulder Innovations?

By market value, Merck & Company ($357B) is about 845.9 times Shoulder Innovations ($422M), at today's prices.

How did MRK and SI stock do over the last 1 years?

Since November 12, 2025, MRK's price moved +61.6% and SI's +37.9%. With dividends: MRK +66.3% (+66.3% a year), SI +37.9% (+37.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or SI?

The dividend yield at today's price is 2.35% for Merck & Company and none for Shoulder Innovations. Over the last twelve months they paid $3.40 and – per share.

Which has the higher profit margins, Merck & Company or Shoulder Innovations?

Over the last twelve months, the net margin was 3.6% for Merck & Company and -51.7% for Shoulder Innovations, and the operating margin – and -54.4%. Revenue was $67.4B and $64M.

Which is the better investment, Merck & Company or Shoulder Innovations?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.